A new research has come up with findings that by conducting a single blood test on men aging 60, the probability of occurrence of prostate cancer can be detected.

The British Medical Journal showcased the findings of the study. The test would help healthy men get rid of unnecessary surgeries and over-diagnosis, the risk that is posed by screening method. A single test would suffice the need to carry out the treatment on the men in danger zone.

The reason for the development of prostate cancer in men is the multiple increase of cells in the prostate gland.

The study was conducted by Professor Philipp Dahm and colleagues at the University of Florida. The findings of the study are based on the appraisal of six prior screening trials involving 387,286 participants.

The researchers found out that though the regular screening helped in the diagnosis of prostate cancer at an earlier stage, but caused no decrease in the death rates and there was a threat of over-treatment.

The projection of the eruption of disease and death arte related to it is possible with a single "prostate-specific antigen" (PSA) level test at age 60, as per a study headed by Professor Hans Lilja.

His crew discovered that 90% of prostate cancer deaths were found in men with the highest PSA levels at age 60. On the other hand, men who had moderate levels were like to die by 85, while with lower levels of PSA had slight rates of prostate cancer or death.